Taxol: Efficacy Against Oral Squamous Cell Carcinoma

Author(s): Kaitlyn Ledwitch, Ryenne Ogburn, Jodi Cox, Rebekah Graham, Allison Fritzsche, Donna Gosnell, Thomas Manning.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 13 , Issue 4 , 2013

Become EABM
Become Reviewer


In medicinal chemistry, one of the most studied molecules in recent history is taxol. Taxol is a versatile natural product that is used in various cancer treatment regimens. It is administered to patients with breast, lung, and ovarian cancers, and is currently being studied for the treatment of squamous cell carcinoma of the oral cavity and tongue. Taxol has been tested in a number of research and clinical phase trials to determine feasibility, toxicity, and cytotoxicity against oral squamous cell carcinoma as a single drug regimen and as a contributing drug component in treatment plans. This paper reviews over forty articles that examine cell lines, murine models, and human results for the response of taxol against squamous cell carcinoma (SCC) of the oral cavity and the tongue.

Keywords: 5-fluorouracil (5-FU), cisplatin, carboplatin, hydroxyurea, hyaluronic acid oral squamous cell carcinoma (OSCC), oxaliplatin, paclitaxel, taxol, oral cancer, tongue cancer,

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [509 - 521]
Pages: 13
DOI: 10.2174/1389557511313040004
Price: $65

Article Metrics

PDF: 31